Immuno-Oncology and Technology
Immuno-Oncology and Technology (IOTECH) is sister journal to Annals of Oncology and ESMO Open and the most recent addition to the European Society for Medical Oncology's portfolio of world-class journals. By publishing high quality original research articles, reviews, perspectives, technology explained papers, letters to the editor and editorials, IOTECH aspires to provide a forum for todays' leaders in the field of Immuno-Oncology.
Editor in Chief:
Professor John Haanen, Professor of Translational Immunotherapy of Cancer Leiden University Medical Center, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amersterdam, The Netherlands
Organizational Affiliations:
European Society for Medical Oncology (ESMO)
2023

Global Print Circulation
Online OnlyAvg. Global Monthly Visits
506Avg. Global Monthly Unique Visitors
388Avg. Global Monthly Page Views
1,064
eTOC Metrics: 6 Month Average of eTOC sends - Nov 2022 to April 2023
Contacts
Display Advertising
-
Bill Hipple United States
646-671-0385
b.hipple@elsevier.com -
Kate Lach Europe
48 500 259 970
k.lach.1@elsevier.com -
Virginia Van Homrigh APAC
61 448 008159
v.vanhomrigh@elsevier.com -
Derek Zakaib Canada
514-730-8837
derekjohnzakaib@gmail.com
Recruitment Advertising
-
Jaesam Hong Global
212-633-3713
j.hong@elsevier.com
Looking for more information?
If you would like to be contacted by one of our advertising experts, please complete our Request Contact form and we will get right back to you.